CN109402265A - Method based on KASP technology detection beta lactoglobulin genotype - Google Patents

Method based on KASP technology detection beta lactoglobulin genotype Download PDF

Info

Publication number
CN109402265A
CN109402265A CN201811182098.1A CN201811182098A CN109402265A CN 109402265 A CN109402265 A CN 109402265A CN 201811182098 A CN201811182098 A CN 201811182098A CN 109402265 A CN109402265 A CN 109402265A
Authority
CN
China
Prior art keywords
blood
primer
buffer
degrees celsius
genotype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811182098.1A
Other languages
Chinese (zh)
Inventor
杨宇泽
路永强
常卓
赵春颖
刘林
赵凤
吕小青
赵凤茹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING DAIRY CATTLE CENTER
Beijing General Station Of Animal Husbandry
Original Assignee
BEIJING DAIRY CATTLE CENTER
Beijing General Station Of Animal Husbandry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING DAIRY CATTLE CENTER, Beijing General Station Of Animal Husbandry filed Critical BEIJING DAIRY CATTLE CENTER
Priority to CN201811182098.1A priority Critical patent/CN109402265A/en
Publication of CN109402265A publication Critical patent/CN109402265A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/124Animal traits, i.e. production traits, including athletic performance or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a kind of methods based on KASP technology detection beta lactoglobulin genotype, include the following steps: to prepare DNA sample;Prepare PCR amplification system;Carry out PCR amplification;Mix primer in PCR amplification system includes three kinds of KASP primers: the unmutated gene primer in upstream, upstream mutated gene primer and downstream primer, also, HEX fluorescence labels sequence and FAM mutation fluorescence labels sequence are respectively designed in the unmutated gene primer in upstream and upstream mutated gene primer;According to the fluorescence intensity of DNA sample after PCR amplification, Genotyping is carried out.The present invention realizes comprehensive screening to two kinds of common variants of BLG gene in milk cow, the resource in the fields such as genetic test and technical advantage can be made full use of to cultivate high-quality kind of ox, excavate milk cow characteristic germ plasm resource, suitable milk cow is selected for pasture, improve milk production trait, the technical bottleneck that related fields is solved from provenance is of great significance to the sound development of milk cow breeding industry.

Description

Method based on KASP technology detection beta lactoglobulin genotype
Technical field
The present invention relates to molecular biology and Biotechnology in Genetic Breeding fields, and in particular to one kind detects β-based on KASP technology The method of lactoglobulin gene type.
Background technique
Beta lactoglobulin (β-lactoglobulin, β-LG) is the peculiar albumen synthesized by galactophore epithelial cell, is generally deposited It is in the milk of a variety of mammals such as reinder, pig, horse, sheep, cat and dog.The lactoprotein of milk is mainly by casein and whey Albumen composition, accounts for about the 80% and 20% of milk total protein respectively, and β-LG is the main component of lactalbumin, accounts for lactalbumin 50%, account for the 12% of total protein.
The main purpose of research milk protein gene polymorphism is that the auxiliary choosing of ox breeding is applied to as genetic marker In selecting.The milk production trait of ox is the quantitative character controlled by multidigit point, genetic force be generally it is medium on the lower side, it is affected by environment Greatly, and milk protein gene site is then one kind in all influential gene locis of multipair milk production trait.It looks forward to the future, from β-cream Globulin present Research can be seen that application potential of the molecular genetics methods in cattle breeding is very big, have wide development Prospect.
Research with the introducing and development of Protocols in Molecular Biology and nucleic acid, largely based on beta lactoglobulin gene Report show the gene pleiomorphism it is significant, coding β-LG albumen gene be referred to as BLG gene, on the locus find A, B, C, D, E, F, G, H and W9 kind Isoforms.Beta lactoglobulin is primarily present two kinds of genetic variants of A, B in cow's milk, causes this at two The site of base replacement is located at the 3rd and the 4th exon of BLG gene.Research has shown that different variants to milk cow cow's milk Component, property and yield have a certain impact, it was found that β-Lg gene pleiomorphism also has an impact to Holstein cow Reproduction.B Variant is preponderant genotype, plays positive improving effect.
The method of detection beta-casein gene type has digestion, sequencing, fluorescent quantitative PCR technique etc., but above method at present It is bothersome, laborious and at high cost.
Summary of the invention
There is solution the shortcomings of the prior art, the present invention provides one kind to detect beta lactoglobulin base based on KASP technology Because of the method for type, include the following steps:
Step S1: preparation DNA sample;
Step S2: PCR amplification system is prepared, wherein the interior DNA sample including 50% volume fraction of the amplification system, The mix primer of 1.2-1.6% volume fraction and the KASP mixed liquor of surplus;
Step S3: PCR amplification is carried out;
Wherein, the mix primer added in step S2 include three kinds of KASP primers, respectively the unmutated gene primer in upstream, Upstream mutated gene primer and downstream primer, also, in the unmutated gene primer in upstream and upstream mutated gene primer respectively Design has HEX fluorescence labels sequence and FAM fluorescence labels sequence, with by the fluorescence intensity according to DNA sample after PCR amplification, Carry out Genotyping.
Wherein, in the step S2, added mix primer includes two groups, is used to detect mutational site at two respectively Base type, also, be directed to different mutational sites, the primer of design is as follows:
(1) when base type on the site LG-118 to be detected, primer includes: upstream mutated gene primer CACCCAGGCACTGGCAGG, the unmutated gene primer CCACCCAGGCACTGGCAGA in upstream and downstream primer AGTACCTGCTCTTCTGCATGGAGAA;
(2) when base type on the site LG-64 to be detected, primer includes: upstream mutated gene primer ATGATCTTCTTCTGAGCACACTCAC, the unmutated gene primer AATGATCTTCTTCTGAGCACACTCAT in upstream and under Swim primer GAAAGCAGCTGTCTTTCAGGGAGAA.
It wherein,, should if corresponding FAM fluorescence intensity only occurs in DNA after amplification when detecting the base type in corresponding site Two chains are mutated on site;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two chains are unmutated on the site; If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated.
Wherein, in the step S3, the step of PCR amplification, includes:
Step S31: when temperature is 90-95 degrees Celsius hot activation 14-16 minutes, 90-95 degrees Celsius of time variation 18-22 Second, it anneals at 65-50 degrees Celsius and extends 55-65 second, carry out 10 and recycle;
Step S32: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extends 55-65 Second, carry out 24-28 circulation;
Step S33: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extends 55-65 Second, carry out 3 circulations.
Wherein, in the step S3, the step of PCR amplification, includes:
Step S31: temperature be 94 degrees Celsius when hot activation 15 minutes, 94 degrees Celsius time variation 20 seconds, 61-55 degrees Celsius When anneal and extend 60 seconds, carry out 10 circulation;
Step S32: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 55 degrees Celsius and extend 60 seconds, carries out 26 Circulation;
Step S33: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 57 degrees Celsius and extend 60 seconds, carries out 3 and follows Ring.
Wherein, in the step S1, the extracting method of DNA sample includes:
Step S11: blood-material is pre-processed;
Step S12: blood-material is successively digested by Porteinase K solution and buffer GB, keeps solution system clear Clearly;
Step S13: addition buffer solution B D mixes well;
Step S14: solution is placed in adsorption column CG2, and waste liquid is abandoned in room temperature centrifugation;
Step S15: being added buffer GDB, and waste liquid is abandoned in room temperature centrifugation;
Step S16: being added buffer PWB, and room temperature centrifugation is abandoned waste liquid, is repeated at least once more;
Step S17: the adsorption column CG2 finally obtained is placed in collecting pipe, and waste liquid is abandoned in room temperature centrifugation;
Step S18: elution adsorption column CG2 it is quantitative to carry out DNA;
Step S19: the integrality of DNA sample is detected by agarose gel electrophoresis.
Wherein, in the step S11, carrying out pretreated step to blood-material includes: that 1- is added into blood sample The cell pyrolysis liquid CL of 2.5 times of volumes, is handled using Syrup-homogenizing instrument, is centrifuged later, and supernatant is abandoned, and leaves nucleus precipitating, Buffer GS is added into nucleus precipitating, oscillation is mixed to thorough;
Wherein, if without blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:1, if there is blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:2.
Wherein, in the step S12, if blood-material is without clot, the body of Porteinase K solution and blood-material Ratio is accumulated as 1:50, the volume ratio of buffer GB and blood-material is 1:5;If blood-material has clot, Porteinase K is molten The volume ratio of liquid and blood-material is 1:25, and the volume ratio of buffer GB and blood-material is 2:5.
Wherein, in the step S13, the volume of added buffer GB in added buffer solution B D and step S12 Than between 1:1-2:1;
In the step S15, the volume ratio of added buffer GB is situated between in added buffer GDB and step S12 In 2:1-3:1;
In the step S16, the volume ratio of added buffer GB is situated between in added buffer PWB and step S12 In 2:1-4:1;
Also, the step S14, into step S16, for the speed of centrifugation between 10000-14000rpm, centrifugation time is equal Between 20-40 seconds;
In the step S17, the speed of centrifugation is between 10000-14000rpm, and centrifugation time is between 1.5-2.5 points.
Wherein, in the step S18, the elution process of adsorption column CG2 includes:
Step S18a: elution buffer TB, the volume that elution buffer TB is added, with step is vacantly added dropwise to adsorption column CG2 The volume ratio of added buffer GB is between 1:4-1:1 in rapid S12;
Step S18b: being placed at room temperature for two minutes, and waste liquid is abandoned in room temperature centrifugation, centrifugal speed between 10000-14000rpm, from The heart time is between 1.5-2.5 points.
Method provided by the invention based on KASP technology detection beta lactoglobulin genotype, realizes to BLG in milk cow Comprehensive screening of two kinds of common variants of gene can make full use of the resource in the fields such as genetic test to cultivate with technical advantage high-quality Kind ox, excavates milk cow characteristic germ plasm resource, selects suitable milk cow for pasture, improves milk production trait, from the related neck of provenance solution The technical bottleneck in domain is of great significance to the sound development of milk cow breeding industry.
Detailed description of the invention
Fig. 1: method one genotyping result figure of the invention based on KASP technology detection beta lactoglobulin genotype.
Specific embodiment
In order to have further understanding to technical solution of the present invention and beneficial effect, it is described in detail with reference to the accompanying drawing Technical solution of the present invention and its beneficial effect of generation.
The present invention is directed to be screened by Genotyping to common variants in three in CSN3 (κ-CN gene) comprehensively, To provide reference for scientific seed selection and selective pairing.
One, the preparation of DNA sample
In the present invention, using the blood of milk cow as extraction, the material of preparation DNA sample.
1, blood-material pre-processes:
(1) it if blood takes 1000ul blood to be tested without blood clot, need to be handled with cell pyrolysis liquid CL, specifically Step: being added the cell pyrolysis liquid CL of 1-2.5 times of volume, be mixed by inversion in sample, 10,000rpm (11,500g) are centrifuged 1min, Supernatant is sucked, nucleus precipitating (if cracking is not thorough, it is primary to repeat above step) is left, to the cell being collected by centrifugation In core precipitating plus 200ul buffer GS, oscillation are mixed to thorough.
(2) if blood has blood clot, 500ul blood clot is taken to be tested, need to be handled with cell pyrolysis liquid CL, specifically Step: in sample be added 1-2.5 times of volume cell pyrolysis liquid CL, handled using Syrup-homogenizing instrument, carried out after being disposed from The heart 10,000rpm (11,500g), 1min, sucks supernatant, leaves nucleus precipitating and (if cracking is not thorough, repeats the above step It is rapid primary), into the nucleus precipitating being collected by centrifugation plus 200ul buffer GS, oscillation are mixed to thorough.
If blood is to freeze state, it need to thaw in 37 DEG C of water-baths, forbid thaw at RT.
It if it is new blood and has been layered, heparin tube gentle inversion need to have been mixed, then carried out taking blood step.
Accordingly, with respect to common kit, the present invention as desired by the additive amount of blood (no blood clot), by 200ul is promoted to 1000ul (blood is without grumeleuse) or 500ul (blood has blood clot) and carries out pre-treatment, makes the base finally extracted Because group DNA concentration is in 100ng/ul or more, detection accuracy is increased.
2, into the blood sample pre-processed, 20ul Porteinase K is added, mixes well.
3,200ul buffer GB is added, is sufficiently mixed by inversion, 56 DEG C of water-bath 10min are mixed by inversion for several times therebetween, make molten Liquid, which sufficiently digests, becomes limpid.
If solution does not become limpid thoroughly, need to extend pyrolysis time until solution is limpid.
4,350ul buffer solution B D is added after being placed at room temperature for 2-5min, is sufficiently mixed by inversion.This step is likely to occur cotton-shaped heavy It forms sediment, but without dispelling.
5, upper step acquired solution and flocculent deposit are added in adsorption column CG2 (adsorption column is put into collecting pipe), room temperature from The heart, 12,000rpm (13,400g), 30sec abandon waste liquid.
6,500ul buffer GDB, room temperature centrifugation, 12,000rpm (13,400g), 30sec, abandoning waste liquid is added.
7,600ul rinsing liquid PWB, room temperature centrifugation, 12,000rpm (13,400g), 30sec, abandoning waste liquid is added.
8,600ul rinsing liquid PWB, room temperature centrifugation, 12,000rpm (13,400g), 30sec, abandoning waste liquid is added.
9, CG2 adsorption column is put back in collecting pipe, room temperature centrifugation, 12,000rpm (13,400g), 2min abandons waste liquid.
10, adsorption column CG2 pipe lid is opened, is placed at room temperature for several minutes, thoroughly to dry remaining rinsing liquid in adsorbent material.
11, adsorption column CG2 is put into a clean 1.5ml EP pipe, is washed to the hanging 50-200ul that is added dropwise in adsorbed film center De- buffer TB is placed at room temperature for 2min, room temperature centrifugation, 12,000rpm (13,400g), 2min.
For the yield for increasing genomic DNA, obtained solution can be rejoined in adsorption column CG2, be placed at room temperature for 2min, Room temperature centrifugation, 12,000rpm (13,400g), 2min.
12, it is quantitative to carry out gDNA, if at once not quantitative, sample is frozen.
13, agarose gel electrophoresis detects gDNA integrality.
Two, the design of primer
Beta lactoglobulin genotyping method of the invention is absorbed in and detects tri- kinds of genotype of A, B and E therein, and three Kind genotype is related to six kinds of different milk cow genomes, also, is related to the catastrophe point everywhere on CSN3.
Table 1 is four group primer sequences and each primer amplification band institute of the present invention for the mutation point design of different location Corresponding base type, table 2 are in the present invention, and six kinds of different milk cow genomes are corresponding on four different mutational sites Base type.
Table 1: primer of the present invention for different mutation point designs
Table 2: corresponding base type on the different mutational sites that the present invention is measured
Genotype β-LG-64 β-LG-118
AA A T
AB GA CT
BB G C
Three, PCR amplification
In the present invention, the PCR system for amplification is 5 μ L, including 2.5 μ L DNA, 2.5 Μ l KASP Master Mix (LGC Genomics, Hoddeston, UK, KASP mixed liquor), 0.07 μ L mix primer.To avoid the erroneous judgement to test result, Blank control, DNA profiling ddH are set2O (distilled water) is replaced.The hot activation when temperature is 94 DEG C of the condition of PCR amplification It anneals when 15min, 94 DEG C of time variation 20s, 61-55 DEG C and extends 60s, carries out 10 circulations;When 94 DEG C of time variation 20s, 55 DEG C Annealing and extension 60s, 26 circulations are carried out;It anneals when 94 DEG C of time variation 20s, 57 DEG C and extends 60s, carries out 3 circulations.
Four, genotyping result
As described above, in table 1 of the invention, every group of PCR amplification primer includes three kinds of amplified bands: the unmutated gene in upstream Primer, upstream mutated gene primer and downstream primer, also, in the unmutated gene primer in upstream and upstream mutated gene primer It is respectively designed with HEX fluorescence labels sequence and FAM fluorescence labels sequence;After PCR amplification, difference can be presented in different DNA samples Fluorescence intensity.By taking LG-118 catastrophe point as an example, incorporated by reference to shown in Fig. 1, it is assumed that certain milk cow (milk cow at this time unmutated here Genotype is AA), then the base type at the position is T, only will appear the corresponding expansion of the unmutated gene primer in upstream after DNA cloning Increase band, that is, HEX, which is presented, in the DNA finally expanded corresponds to fluorescence intensity, the i.e. color (navy blue) in the upper left corner Fig. 1;Assuming that certain milk Ox has the mutation of chain (genotype of milk cow is AB at this time) here, then the base type of a chain is C at the position, and another For T, can occur the unmutated gene primer in upstream and the corresponding amplified band of upstream mutated gene primer simultaneously after DNA cloning, that is, The DNA presentation HEX finally expanded corresponds to fluorescence intensity and FAM corresponds to the secondary colour of fluorescence intensity, i.e. iridescent among Fig. 1; Assuming that two chains are mutated (genotype of milk cow is BB at this time) to certain milk cow here, then base type is C at the position, and DNA expands It only will appear mutated gene primer corresponding amplified band in upstream after increasing, to correspond to fluorescence strong that is, FAM is presented in the DNA that finally expands The color of degree, the i.e. color (red) in the lower right corner Fig. 1.
It, can also by the fluorescence intensity of the corresponding amplification of amplified band corresponding at another place mutational site LG-64 To judge the genotype of milk cow, principle is similar as above, and the present invention does not add tired state.
It is so-called " Proteinase K solution " in the present invention, refer to Proteinase K Solution;So-called cell pyrolysis liquid CL, Buffer GDB, buffer GB, buffer GS, buffer PWB, buffer solution B D, adsorption column CG2 and eluent TB, are selected from day Root kit self-contained reagent.
Method provided by the invention based on KASP technology detection beta lactoglobulin genotype, realizes to BLG in milk cow Comprehensive screening of two kinds of common variants of gene can make full use of the resource in the fields such as genetic test to cultivate with technical advantage high-quality Kind ox, excavates milk cow characteristic germ plasm resource, selects suitable milk cow for pasture, improves milk production trait, from the related neck of provenance solution The technical bottleneck in domain is of great significance to the sound development of milk cow breeding industry.
The breeding plan that the genotyping result provided through the invention carries out genetic improvement, which can be convenient, quickly to be implemented, and can To be generalized in the analysis of gene loci, can be answered according to its genotype combination production performance and physical efficiency character and heredity estimation For matching system and breeding practice, as long as finding ideal type male animal in group, DNA typing combination artificial insemination, embryo are utilized The methods of tire transplanting and breeding estimation, so that it may so that the ideal genotype with excellent genetic background is fixed rapidly, compared to more sharp With the method for genetic engineering, the present invention does not have any risk, easy to be reliable, in production practice, to raising merit Operability is stronger for genetic progress.
Although the present invention is illustrated using above-mentioned preferred embodiment, the protection model that however, it is not to limit the invention It encloses, anyone skilled in the art are not departing within the spirit and scope of the present invention, and opposite above-described embodiment carries out various changes It is dynamic still to belong to the range that the present invention is protected with modification, therefore protection scope of the present invention subjects to the definition of the claims.

Claims (10)

1. a kind of method based on KASP technology detection beta lactoglobulin genotype, which comprises the steps of:
Step S1: preparation DNA sample;
Step S2: PCR amplification system is prepared, wherein DNA sample, 1.2- in the amplification system including 50% volume fraction The mix primer of 1.6% volume fraction and the KASP mixed liquor of surplus;
Step S3: PCR amplification is carried out;
Wherein, the mix primer added in step S2 includes three kinds of KASP primers, the respectively unmutated gene primer in upstream, upstream Mutated gene primer and downstream primer, also, separately designed in the unmutated gene primer in upstream and upstream mutated gene primer There are HEX fluorescence labels sequence and FAM fluorescence labels sequence, to carry out by the fluorescence intensity according to DNA sample after PCR amplification Genotyping.
2. the method as described in claim 1 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that described In step S2, added mix primer includes two groups, is used to detect the base type in mutational site at two respectively, also, For different mutational sites, the primer of design is as follows:
(1) when base type on the site LG-118 to be detected, primer includes: upstream mutated gene primer CACCCAGGCACTGGCAGG, the unmutated gene primer CCACCCAGGCACTGGCAGA in upstream and downstream primer AGTACCTGCTCTTCTGCATGGAGAA;
(2) when base type on the site LG-64 to be detected, primer includes: upstream mutated gene primer ATGATCTTCTTCTGAGCACACTCAC, the unmutated gene primer AATGATCTTCTTCTGAGCACACTCAT in upstream and under Swim primer GAAAGCAGCTGTCTTTCAGGGAGAA.
3. the method as claimed in claim 2 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that detection When base type in corresponding site, if corresponding FAM fluorescence intensity only occurs in DNA after amplification, two chains are dashed forward on the site Become;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two chains are unmutated on the site;If DNA occurs after amplification Two kinds of mixing fluorescence intensities, then two one, chain mutation on the site, one unmutated.
4. the method as described in claim 1 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that described In step S3, the step of PCR amplification, includes:
Step S31: temperature be 90-95 degrees Celsius when hot activation 14-16 minutes, 90-95 degrees Celsius time variation 18-22 seconds, 65- It anneals and extends 55-65 seconds at 50 degrees Celsius, carry out 10 circulations;
Step S32: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extend 55-65 seconds, Carry out 24-28 circulation;
Step S33: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extend 55-65 seconds, Carry out 3 circulations.
5. the method as claimed in claim 4 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that described In step S3, the step of PCR amplification, includes:
Step S31: it is moved back when temperature being 94 degrees Celsius hot activation 15 minutes, 94 degrees Celsius time variation 20 seconds, 61-55 degrees Celsius Fire and extension 60 seconds, carry out 10 circulations;
Step S32: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 55 degrees Celsius and extend 60 seconds, carries out 26 circulations;
Step S33: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 57 degrees Celsius and extend 60 seconds, carries out 3 circulations.
6. the method as described in claim 1 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that described In step S1, the extracting method of DNA sample includes:
Step S11: blood-material is pre-processed;
Step S12: blood-material is successively digested by Porteinase K solution and buffer GB, clarifies solution system;
Step S13: addition buffer solution B D mixes well;
Step S14: solution is placed in adsorption column CG2, and waste liquid is abandoned in room temperature centrifugation;
Step S15: being added buffer GDB, and waste liquid is abandoned in room temperature centrifugation;
Step S16: being added buffer PWB, and room temperature centrifugation is abandoned waste liquid, is repeated at least once more;
Step S17: the adsorption column CG2 finally obtained is placed in collecting pipe, and waste liquid is abandoned in room temperature centrifugation;
Step S18: elution adsorption column CG2 it is quantitative to carry out DNA;
Step S19: the integrality of DNA sample is detected by agarose gel electrophoresis.
7. the method as claimed in claim 6 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that described In step S11, the cell that pretreated step includes: the 1-2.5 times of volume of addition into blood sample is carried out to blood-material and is split Liquid CL is solved, is handled using Syrup-homogenizing instrument, is centrifuged later, supernatant is abandoned, leaves nucleus precipitating, is added into nucleus precipitating Buffer GS, oscillation are mixed to thorough;
Wherein, if without blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:1, If there is blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:2.
8. the method as claimed in claim 6 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that described In step S12, if blood-material, without clot, the volume ratio of Porteinase K solution and blood-material is 1:50, buffer The volume ratio of GB and blood-material is 1:5;If blood-material has clot, the volume of Porteinase K solution and blood-material Than for 1:25, the volume ratio of buffer GB and blood-material is 2:5.
9. the method as claimed in claim 6 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that
In the step S13, the volume ratio of added buffer GB is between 1:1- in added buffer solution B D and step S12 2:1;
In the step S15, the volume ratio of added buffer GB is between 2 in added buffer GDB and step S12: 1-3:1;
In the step S16, the volume ratio of added buffer GB is between 2 in added buffer PWB and step S12: 1-4:1;
Also, the step S14 is into step S16, the speed of centrifugation between 10000-14000rpm, centrifugation time between 20-40 seconds;
In the step S17, the speed of centrifugation is between 10000-14000rpm, and centrifugation time is between 1.5-2.5 points.
10. the method as claimed in claim 6 based on KASP technology detection beta lactoglobulin genotype, which is characterized in that institute It states in step S18, the elution process of adsorption column CG2 includes:
Step S18a: elution buffer TB, the volume that elution buffer TB is added, with step S12 is vacantly added dropwise to adsorption column CG2 In added buffer GB volume ratio between 1:4-1:1;
Step S18b: being placed at room temperature for two minutes, and waste liquid is abandoned in room temperature centrifugation, and centrifugal speed is between 10000-14000rpm, when centrifugation Between between 1.5-2.5 point.
CN201811182098.1A 2018-10-10 2018-10-10 Method based on KASP technology detection beta lactoglobulin genotype Pending CN109402265A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811182098.1A CN109402265A (en) 2018-10-10 2018-10-10 Method based on KASP technology detection beta lactoglobulin genotype

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811182098.1A CN109402265A (en) 2018-10-10 2018-10-10 Method based on KASP technology detection beta lactoglobulin genotype

Publications (1)

Publication Number Publication Date
CN109402265A true CN109402265A (en) 2019-03-01

Family

ID=65467578

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811182098.1A Pending CN109402265A (en) 2018-10-10 2018-10-10 Method based on KASP technology detection beta lactoglobulin genotype

Country Status (1)

Country Link
CN (1) CN109402265A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103293317A (en) * 2013-04-28 2013-09-11 浙江省疾病预防控制中心 Cow milk beta-lactoglobulin quantitative determination kit and application thereof
CN107058582A (en) * 2017-06-06 2017-08-18 北京奶牛中心 The method that β casein genotypes are detected based on KASP
CN107099607A (en) * 2017-06-12 2017-08-29 山东省农业科学院奶牛研究中心 It is a set of while detecting primer combination and the kit of 93 kinds of ox genetic defect genes and lethal haplotype
WO2018002017A2 (en) * 2016-06-29 2018-01-04 Tine Sa Quantitative trait loci affecting fatty acid composition in milk

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103293317A (en) * 2013-04-28 2013-09-11 浙江省疾病预防控制中心 Cow milk beta-lactoglobulin quantitative determination kit and application thereof
WO2018002017A2 (en) * 2016-06-29 2018-01-04 Tine Sa Quantitative trait loci affecting fatty acid composition in milk
CN107058582A (en) * 2017-06-06 2017-08-18 北京奶牛中心 The method that β casein genotypes are detected based on KASP
CN107099607A (en) * 2017-06-12 2017-08-29 山东省农业科学院奶牛研究中心 It is a set of while detecting primer combination and the kit of 93 kinds of ox genetic defect genes and lethal haplotype

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JUAN FERNANDO MEDRANO等: "Polymerase chain reaction amplification of bovine β‐lactoglobulin genomic sequences and identification of genetic variants by RFLP analysis", 《ANIMAL BIOTECHNOLOGY》 *
LGC公司: "KASP genotyping chemistry User guide and manual", 《LGC公司》 *
TIANGEN: "TIANamp Blood DNA Kit血液基因组DNA提取试剂盒", 《原创力文档》 *

Similar Documents

Publication Publication Date Title
US20060147925A1 (en) Method of detection
CN105886608A (en) ApoE gene primer group, detection kit and detection method
KR910012263A (en) Chromosomal-Specific Staining Compositions and Staining Methods
US20030162197A1 (en) Method of detecting neoplastic or non-neoplastic cells
CA2525122A1 (en) Identification of clonal cells by repeats in t-cell receptor and immunoglobulin v/d/j genes
CN105368930B (en) The determination method that enzymes combinations are sequenced in genotyping technique is sequenced
CN110527710B (en) Primer, probe and kit for detecting NTRK gene fusion mutation
CN107868834B (en) Real-time quantitative PCR detection primer group and method for Acipenser dabryanus gonad differential expression gene
CN111719008B (en) SNP coseparated with wheat powdery mildew disease-resistant gene Pm5e and application thereof
WO2023001212A1 (en) Gene chip, molecular probe combination and kit for analyzing sheep milk production performance, and use
CN109112217A (en) A kind of and pig body length and the significantly associated genetic marker of number of nipples and application
CN109321639A (en) κ-casein genotype method is detected based on KASP technology
CN112210619B (en) Primer pair for detecting bicuspid plum blossom yeast and application thereof
CN106086193B (en) A method of mixing sample DNA is analyzed based on INDEL-SNP linkage relationship
CN108570506A (en) A kind of primer, kit and detection method for detecting rose comb locus gene
CN109402265A (en) Method based on KASP technology detection beta lactoglobulin genotype
CN113462783A (en) Brain glioma chromosome lp/19q detection method based on MassArray nucleic acid mass spectrum and application thereof
CN114196740A (en) Digital amplification detection method, detection product and detection kit for simultaneously identifying multiple gene types
CN112029833A (en) Rapid identification method of CTNNB1 gene mutation for tumor organoid culture condition selection
CN108531620B (en) Primer and method for identifying acipenser schrencki, acipenser sibiricus and filial generation thereof
CN108660223B (en) Siberian sturgeon and identification method of Siberian sturgeon
CN114480615B (en) Primer group and kit for detecting HLA-B5101 alleles
CN113667714B (en) Target area capturing method, kit and sequencing method
CN108660224B (en) Primer and method for identifying Siberian sturgeons, Acipenser schrenki and filial generations thereof
CN113621719B (en) Rapid detection method and application of Edwardsiella tarda

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190301